Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease

Area of Science:

• Nephrology
• Mitochondrial Biology
• Cellular Pathology

Background:

• Chronic kidney disease (CKD) is a progressive condition characterized by irreversible kidney damage, often leading to end-stage kidney disease (ESKD) and the need for transplantation.
• Mitochondria, abundant in kidney cells, play a critical role in cellular energy production and are susceptible to damage in CKD.
• Mitochondrial dysfunction is a recognized hallmark of kidney injury in CKD, manifesting as structural and functional alterations.

Purpose of the Study:

• To summarize recent advancements and novel insights into the role of mitochondrial remodeling in the progression of chronic kidney disease.
• To highlight the sources of acquired mitochondrial dysfunction in CKD.
• To underscore the importance of understanding mitochondrial biology for developing effective CKD treatments.

Main Methods:

• Review of current scientific literature focusing on mitochondrial dynamics and function in the context of chronic kidney disease.
• Analysis of studies investigating the relationship between kidney inflammation, injury, and mitochondrial alterations.
• Synthesis of findings related to changes in mitochondrial morphology, oxidative stress, biogenesis, and ATP production in CKD.

Main Results:

• CKD is associated with significant alterations in mitochondrial morphology and remodeling within kidney tissues.
• Increased mitochondrial oxidative stress and a decline in ATP generation are common features of mitochondrial dysfunction in CKD.
• These mitochondrial changes are linked to kidney inflammatory responses and overall injury progression.

Conclusions:

• Mitochondrial remodeling and dysfunction are integral to the pathogenesis and advancement of chronic kidney disease.
• Understanding the specific mechanisms of mitochondrial dysfunction in CKD is crucial for identifying therapeutic targets.
• Further research into kidney mitochondrial biology holds promise for developing novel treatment strategies for CKD and preventing its progression to ESKD.